Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1074 studies found for:    "Hepatitis C, Chronic"
Show Display Options
Rank Status Study
1 Completed Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Irbesartan;   Drug: placebo
2 Completed
Has Results
Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548)
Condition: Hepatitis C, Chronic
Interventions: Biological: peginterferon alfa-2b (SCH 54031);   Drug: ribavirin (SCH 18908)
3 Completed Multidisciplinary Support Program in Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Other: Multidisciplinary support program
4 Completed A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants
Condition: Hepatitis C, Chronic
Interventions: Drug: Simeprevir;   Drug: Daclatasvir
5 Completed Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Peg-interferon alpha 2a (drug);   Drug: Ribavirin (drug);   Drug: Interferon gamma (drug)
6 Active, not recruiting Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection
Condition: Hepatitis C, Chronic
Intervention: Biological: VGX-6150
7 Completed Evaluating Silymarin for Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Drug: Silymarin (milk thistle)
8 Completed Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Condition: Hepatitis C, Chronic
Interventions: Drug: GSK2336805;   Drug: Pegylated interferon alfa-2a;   Drug: Ribavirin;   Drug: GSK2336805 Matching Placebo
9 Completed A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation
Condition: Hepatitis C, Chronic
Interventions: Drug: Simeprevir;   Drug: Daclatasvir;   Drug: Ribavirin;   Drug: Cyclosporine;   Drug: Tacrolimus
10 Recruiting Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: AL-335;   Drug: Odalasvir;   Drug: Simeprevir
11 Active, not recruiting An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease
Condition: Hepatitis C, Chronic
Interventions: Drug: Simeprevir;   Drug: Daclatasvir;   Drug: Sofosbuvir
12 Completed Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.
Condition: Hepatitis C, Chronic
Interventions: Drug: GSK2878175;   Drug: Placebo
13 Recruiting Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Drug: Daclinza and Sunvepra
14 Completed
Has Results
Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Participants With/Without Substitution Therapy (P05255)
Condition: Hepatitis C, Chronic
Interventions: Biological: Pegylated interferon alfa-2b (PegIFN-2b);   Drug: Ribavirin
15 Terminated Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Viramidine;   Drug: Peginterferon alfa-2b
16 Completed Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Procedure: Liver Biopsy;   Drug: Peginterferon & Ribavirin for Hepatitis C;   Drug: Pre-treatment Ribavirin
17 Terminated
Has Results
Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P07614)
Condition: Hepatitis C, Chronic
Intervention: Drug: Boceprevir
18 Terminated
Has Results
The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833)
Condition: Hepatitis C, Chronic
Interventions: Biological: PegIntron (peginterferon alfa-2b);   Drug: Rebetol (ribavirin)
19 Completed
Has Results
A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
20 Completed
Has Results
Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)
Condition: Hepatitis C, Chronic
Interventions: Biological: peginterferon alfa-2b (PEG2b) (SCH 54031);   Drug: ribavirin (SCH 18908)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.